Hidradenitis suppurativa in paediatric patients: a retrospective monocentric study in Germany and review of the literature.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
16
02
2020
accepted:
10
04
2020
pubmed:
24
4
2020
medline:
15
5
2021
entrez:
24
4
2020
Statut:
ppublish
Résumé
Hidradenitis suppurativa (HS) is a chronic, inflammatory, recurrent, debilitating skin disease of the hair follicle affecting apocrine glands-rich areas of the body. The disease usually occurs after puberty leading to painful nodules, abscesses, tunnels and scarring. Although uncommonly, HS can also occur in children and adolescents. Our objective was to describe the epidemiology, characteristics, predisposing factors and clinical course of HS in paediatric patients. The retrospective cohort study included patients with HS, who have been diagnosed in Dessau Medical Center and reported development of HS during childhood or adolescence, fulfilled the diagnostic criteria for HS and had a follow-up period of at least one year. A systematic review was conducted on MEDLINE, EMBASE and CENTRAL on 19 March 2020 using the terms 'hidradenitis' or 'acne inversa' together with the terms 'children', 'paediatric' and 'adolescence'. Twenty paediatric patients [1 child (0.22%), 19 adolescents (4.25%)] were detected out of 447 patients evaluated (4.5%) with a male to female ratio of 1.86 : 1. The median age at diagnosis was 17 years [interquartile range (IQR) 16-18] and the median age at onset 15 years (IQR: 14-16.5). The majority of the patients suffered from moderate disease were overweight or obese and non-smokers. The most common comorbid disorder was acne vulgaris. The systematic review revealed reports with data heterogeneity and lack of systematic documentation of specific demographic characteristics. Most paediatric patients were female, obese and non-smokers, with considerable comorbid disorders. Hidradenitis suppurativa in Germany may affect children and adolescents exhibiting a particular phenotype of mainly male non-smokers.
Sections du résumé
BACKGROUND
BACKGROUND
Hidradenitis suppurativa (HS) is a chronic, inflammatory, recurrent, debilitating skin disease of the hair follicle affecting apocrine glands-rich areas of the body. The disease usually occurs after puberty leading to painful nodules, abscesses, tunnels and scarring. Although uncommonly, HS can also occur in children and adolescents.
OBJECTIVE
OBJECTIVE
Our objective was to describe the epidemiology, characteristics, predisposing factors and clinical course of HS in paediatric patients.
METHODS
METHODS
The retrospective cohort study included patients with HS, who have been diagnosed in Dessau Medical Center and reported development of HS during childhood or adolescence, fulfilled the diagnostic criteria for HS and had a follow-up period of at least one year. A systematic review was conducted on MEDLINE, EMBASE and CENTRAL on 19 March 2020 using the terms 'hidradenitis' or 'acne inversa' together with the terms 'children', 'paediatric' and 'adolescence'.
RESULTS
RESULTS
Twenty paediatric patients [1 child (0.22%), 19 adolescents (4.25%)] were detected out of 447 patients evaluated (4.5%) with a male to female ratio of 1.86 : 1. The median age at diagnosis was 17 years [interquartile range (IQR) 16-18] and the median age at onset 15 years (IQR: 14-16.5). The majority of the patients suffered from moderate disease were overweight or obese and non-smokers. The most common comorbid disorder was acne vulgaris. The systematic review revealed reports with data heterogeneity and lack of systematic documentation of specific demographic characteristics. Most paediatric patients were female, obese and non-smokers, with considerable comorbid disorders.
CONCLUSIONS
CONCLUSIONS
Hidradenitis suppurativa in Germany may affect children and adolescents exhibiting a particular phenotype of mainly male non-smokers.
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2140-2146Informations de copyright
© 2020 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
Références
ZouboulisCC, Desai N, Emtestam Let al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol 2015; 29: 619-644.
ZouboulisCC, Tzellos T, Kyrgidis Aet al. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol 2017; 177: 1401-1409.
Lindsø AndersenP, Kromann C, Fonvig CE, Theut Riis P, Jemec GBE, Holm JC. Hidradenitis suppurativa in a cohort of overweight and obese children and adolescents. Int J Dermatol 2019; 20: 47-51.
OffidaniA, Molinelli E, Sechi Aet al. Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines. J Eur Acad Dermatology Venereol 2019; 33: 28-31.
Liy-WongC, Pope E, Lara-Corrales I. Hidradenitis suppurativa in the pediatric population. J Am Acad Dermatol 2015; 1: 36-41.
PalmerRA, Keefe M. Early-onset hidradenitis suppurativa. Clin Exp Dermatol 2001; 26: 501-503.
KirstenN, Petersen J, Hagenström K, Augustin M. Epidemiology of hidradenitis suppurativa in Germany - an observational cohort study based on a multisource approach. J Eur Acad Dermatol Venereol 2020; 34: 174-179.
VazquezBG, Alikhan A, Weaver AL, Wetter DA, Davis MD. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol 2013; 133: 97-103.
GargA, Wertenteil S, Baltz R, Strunk A, Finelt N. Prevalence estimates for hidradenitis suppurativa among children and adolescents in the United States: a gender- and age-adjusted population analysis. J Invest Dermatol 2018; 138: 2152-2156.
CosmatosI, Matcho A, Weinstein R, Montgomery MO, Stang P. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol 2013; 68: 412-419.
DeckersIE, Van Der Zee HH, Boer J, Prens EP. Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement. J Am Acad Dermatol 2015; 72: 485-488.
ScheinfeldN. Hidradenitis suppurativa in prepubescent and pubescent children. Clin Dermatol 2015; 33: 316-319.
MengeshaYM, Holcombe TC, Hansen RC. Prepubertal hidradenitis suppurativa: two case reports and review of the literature. Pediatr Dermatol 1999; 16:292-296.
Stojkovic-FilipovicJM, Gajic-Veljic MD, Nikolic M. Prepubertal onset of hidradenitis suppurativa in a girl: a case report and literature review. Indian J Dermatol Venereol Leprol 2015; 81: 294-298.
JourdainJC, Le Lorier B, Mourier C, Ploussard JP, Roussel F. Virilization caused by 21-hydroxylase deficiency and axillary sweat gland hyperplasia. Ann Dermatol Venereol 1988; 115: 1136-1138.
LewisF, Messenger AG, Wales JKH. Hidradenitis suppurativa as a presenting feature of premature adrenarche. Br J Dermatol 1993; 129: 447-448.
LopesS, Gomes N, Trindade E, Azevedo F, Magina S. Hidradenitis suppurativa in a prepubertal girl. Acta Dermatovenerol Alp Pannonica Adriat 2019; 28: 139-141.
ZouboulisCC, del Marmol V, Mrowietz U, Prens E, Tzellos T, Jemec GBE. Hidradenitis supurativa/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology 2015; 231: 184-190.
DaxheletM, Djamei V, Suppa Met al. Establishment of an European Registry for hidradenitis suppurativa/ acne inversa by using an open source software. J Eur Acad Dermatol Venereol 2016; 30: 1424-1426.
TiriH, Jokelainen J, Timonen M, Tasanen K, Huilaja L. Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents. J Am Acad Dermatol 2018; 79: 514-519.
FirsowiczM, Boyd M, Jacks SK. Follicular occlusion disorders in Down syndrome patients. Pediatr Dermatol 2020; 37: 219-221.
ReichertB, Fernandez Faith E, Harfmann K. Weight counseling in pediatric hidradenitis suppurativa patients. Pediatr Dermatol 2020 [Epub ahead of print].
BalgobindA, Finelt N, Strunk A, Garg A. Association between obesity and hidradenitis suppurativa among children and adolescents: a population-based analysis in the United States. J Am Acad Dermatol 2020; 82: 502-504.
RiisPT, Saunte DM, Sigsgaard Vet al. Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients. Arch Dermatol Res 2020. [Epub ahead of print].
ChoiE, Cook AR, Chandran NS. Hidradenitis suppurativa: an Asian perspective from a Singaporean institute. Skin Appendage Disord 2018; 4: 281-285.
BraunbergerTL, Nicholson CL, Gold Let al. Hidradenitis suppurativa in children: the henry ford experience. Pediatr Dermatol 2018; 35: 370-373.
BettoliV, Ricci M, Zauli S, Virgili A. Hidradenitis suppurativa-acne inversa: a relevant dermatosis in paediatric patients. Br J Dermatol 2015; 173: 1328-1330.
EspositoC, Del Conte F, Cerulo Met al. Pediatric endoscopic hidradenitis treatment: a new minimally invasive treatment for pediatric patients with hidradenitis suppurativa. J Laparoendosc Adv Surg Tech A 2020; 30: 464-470.
GeS, Ngaage LM, Orbay H, Silverman RP, Rasko YM, Rada EM. Surgical management of pediatric hidradenitis suppurativa. Ann Plast Surg 2020; 84: 570-574.
TzellosT, Zouboulis CC. Review of comorbidities of hidradenitis suppurativa: implications for daily clinical practice. Dermatol Ther (Heidelb) 2020; 10: 63-71 (Erratum: 2020;10:523).
LeeHH, Patel KR, Singam V, Rastogi S, Silverberg JI. Associations of cutaneous and extracutaneous infections with hidradenitis suppurativa in U.S. children and adults. Br J Dermatol 2020; 182: 327-334.